APA (7th ed.) Citation

Jordan, K., Chan, A., Gralla, R. J., Jahn, F., Rapoport, B. L., Ruhlmann, C. H., . . . Hesketh, P. (2024). Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents: Updated MASCC/ESMO consensus recommendation. Supportive care in cancer, 32, . https://doi.org/10.1007/s00520-023-08220-5

Chicago Style (17th ed.) Citation

Jordan, Karin, Alexandre Chan, Richard J. Gralla, Franziska Jahn, Bernardo L. Rapoport, Christina H. Ruhlmann, Paula Sayegh, and Paul Hesketh. "Emetic Risk Classification and Evaluation of the Emetogenicity of Antineoplastic Agents: Updated MASCC/ESMO Consensus Recommendation." Supportive Care in Cancer 32 (2024). https://doi.org/10.1007/s00520-023-08220-5.

MLA (9th ed.) Citation

Jordan, Karin, et al. "Emetic Risk Classification and Evaluation of the Emetogenicity of Antineoplastic Agents: Updated MASCC/ESMO Consensus Recommendation." Supportive Care in Cancer, vol. 32, 2024, https://doi.org/10.1007/s00520-023-08220-5.